Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Akari Therapeutics (NQ: AKTX )

2.800 USD -0.130 (-4.44%)
Official Closing Price Updated: 7:54 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 121,900
Open 2.900
Bid (Size) 2.600 (2)
Ask (Size) 2.700 (3)
Prev. Close 2.930
Today's Range 2.620 - 2.900
52wk Range 0.8700 - 4.210
Shares Outstanding 15,256,933
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Akari Therapeutics Announces a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR) for Nomacopan in Trauma
Study of porcine model of blast injury and haemorrhagic shock underway with USAISR as part of the development of a clinical path for the use of nomacopan to treat trauma 
From GlobeNewswire News Releases
Akari Therapeutics Presents New Preclinical Data Highlighting Potential of Long-Acting PASylated Nomacopan to Treat Retinal Diseases, Including Age-Related Macular Degeneration (AMD) and Uveitis
From GlobeNewswire News Releases

Performance

YTD
+54.70%
+54.70%
1 Month
+2.19%
+2.19%
3 Month
+47.37%
+47.37%
6 Month
+77.22%
+77.22%
1 Year
+53.85%
+53.85%

More News

Read More
Akari Therapeutics Adds Histamine Inhibitor Votucalis to Pipeline to treat Neuropathic Pain and Dermatological Disease
From GlobeNewswire News Releases
Akari Therapeutics to Participate in Two January Virtual Investor Conferences
From GlobeNewswire News Releases
Akari Therapeutics Reports Third Quarter 2020 Financial Results and Highlights Recent Clinical Progress
From GlobeNewswire News Releases
Akari Therapeutics Announces New Clinical Data that Show Long-Term Self-Administered Nomacopan is Well-Tolerated and Substantially Reduces Transfusion Dependence in Patients with Paroxysmal Nocturnal
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tags TTOO BZI/TFM Pre/Market Outlook
From Benzinga
Akari Therapeutics Announces Publication in American Journal of Pathology Highlighting Potential of Nomacopan in Treatment of Uveitis and Retinal Disease
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Thursday's After-Market Session
Tags SLRX CFMS After/Hours Center
From Benzinga
Akari Therapeutics' PASylated Nomacopan Shows Promising Action In Animal Studies
Tags Penny Stocks News Biotech
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Tags PSTV BZI/TFM Market News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.